Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Comparing the Efficacy of the Artificial Pancreas with and without a Learning Component in Children and Adolescents with Type 1 Diabetes in a Diabetes Camp

EF 2017-18

Résumé
Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of pancreatic cells responsible for producing insulin. Insulin is needed to control blood glucose levels. Once diagnosed, patients with T1D are treated with insulin replacement for life. Good glycemic control is needed to reduce microvascular and macrovascular complications. However, achieving ideal glycemic levels is more difficult than it seems, and most T1D patients do not achieve these goals.In healthy individuals, insulin is released from the pancreas at small amounts all day. This is defined as the basal insulin secretion. After a meal, the pancreas will release a larger amount of insulin, called the bolus insulin. Basal-bolus insulin treatment for T1D aims to mimic this healthy pattern. Optimal basal-bolus settings are the ideal settings that will achieve satisfactory glycemic control, but many T1D patients have inaccurate settings because finding these periodically changing settings is challenging.The artificial pancreas is the future of therapies for T1D. The artificial pancreas is made up of three parts: a continuous glucose sensor, a computer program that calculates insulin infusion, and a pump that continually administers insulin. Basal-bolus settings are also used to initialize the AP. However, these parameters are often suboptimal, which can deteriorate the performance of the artificial pancreas. The purpose of this study is to evaluate the feasibility of an algorithm that can optimize basal-bolus settings using a cross-over randomized trial with children and adolescents with T1D in a camp. Hopefully, the artificial pancreas with the algorithm will improve glycemic control in patients with T1D more than with artificial pancreas alone.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386649
Name
Palisaitis Emilie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comparing the Efficacy of the Artificial Pancreas with and without a Learning Component in Children and Adolescents with Type 1 Diabetes in a Diabetes Camp
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Artificial Pancreas; Closed-Loop Therapy; Learning Algorithm; Pediatric; Type 1 Diabetes
Abstract
Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of pancreatic cells responsible for producing insulin. Insulin is needed to control blood glucose levels. Once diagnosed, patients with T1D are treated with insulin replacement for life. Good glycemic control is needed to reduce microvascular and macrovascular complications. However, achieving ideal glycemic levels is more difficult than it seems, and most T1D patients do not achieve these goals.In healthy individuals, insulin is released from the pancreas at small amounts all day. This is defined as the basal insulin secretion. After a meal, the pancreas will release a larger amount of insulin, called the bolus insulin. Basal-bolus insulin treatment for T1D aims to mimic this healthy pattern. Optimal basal-bolus settings are the ideal settings that will achieve satisfactory glycemic control, but many T1D patients have inaccurate settings because finding these periodically changing settings is challenging.The artificial pancreas is the future of therapies for T1D. The artificial pancreas is made up of three parts: a continuous glucose sensor, a computer program that calculates insulin infusion, and a pump that continually administers insulin. Basal-bolus settings are also used to initialize the AP. However, these parameters are often suboptimal, which can deteriorate the performance of the artificial pancreas. The purpose of this study is to evaluate the feasibility of an algorithm that can optimize basal-bolus settings using a cross-over randomized trial with children and adolescents with T1D in a camp. Hopefully, the artificial pancreas with the algorithm will improve glycemic control in patients with T1D more than with artificial pancreas alone.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Palisaitis, Emilie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~